Dermapharm Holding Dividends and Buybacks
Dividend criteria checks 3/6
Dermapharm Holding is a dividend paying company with a current yield of 2.81% that is well covered by earnings.
Key information
2.8%
Dividend yield
n/a
Buyback Yield
Total Shareholder Yield | n/a |
Future Dividend Yield | 3.8% |
Dividend Growth | 11.9% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Payout ratio | 46% |
Recent dividend and buyback updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: DMPD has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: DMPD's dividend payments have increased, but the company has only paid a dividend for 4 years.
Dividend Yield vs Market
Dermapharm Holding Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (DMPD) | 2.8% |
Market Bottom 25% (GB) | 2.1% |
Market Top 25% (GB) | 5.8% |
Industry Average (Pharmaceuticals) | 2.5% |
Analyst forecast (DMPD) (up to 3 years) | 3.8% |
Notable Dividend: DMPD's dividend (2.81%) is higher than the bottom 25% of dividend payers in the UK market (2.25%).
High Dividend: DMPD's dividend (2.81%) is low compared to the top 25% of dividend payers in the UK market (5.94%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (45.9%), DMPD's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (21.1%), DMPD's dividend payments are well covered by cash flows.